FdaApplication
NDA 218764
Identifiers
- fda_app_no: NDA218764
Properties
| Property | Value |
|---|---|
| applicant_name | BOEHRINGER INGELHEIM PHARMACEUTICALS INC |
| application_type | NDA |
| approval_date | 2025-10-07 |
Products (2)
| Product | Active ingredient | Strength | Dosage form |
|---|---|---|---|
| JASCAYD | NERANDOMILAST | 9MG | TABLET;ORAL |
| JASCAYD | NERANDOMILAST | 18MG | TABLET;ORAL |
2 products